(133 days)
No
The description focuses on traditional image-guided surgery techniques using optical tracking and registration, without mentioning AI/ML algorithms for image analysis, planning, or tracking.
No
The device is a surgical planning and navigation tool that assists surgeons in localizing targets, not directly treating a disease or condition.
No
Explanation: The device is described as a "graphical planning tool" and an "interactive, image-guided means of localizing targets in surgical procedures." Its function is to facilitate pre-operative and operative planning and target localization during surgery, rather than to diagnose a condition.
No
The device description explicitly states that the OTS consists of a camera array, computer workstation, application software, and probes, indicating it includes hardware components beyond just software.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body (like blood, urine, or tissue) to detect diseases, conditions, or infections. They are used to provide information for diagnosis, monitoring, or screening.
- Device Function: The Optical Tracking System (OTS) described here is a surgical navigation tool. It uses imaging data (CT and MR) and optical tracking to guide surgeons during cranial and spinal procedures. It helps localize targets and avoid critical structures during the surgery.
- Lack of Biological Sample Analysis: The description does not mention the analysis of any biological samples from the patient. The system works with pre-operative imaging data and real-time tracking of surgical tools and the patient's anatomy.
Therefore, the OTS falls under the category of a surgical navigation system, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Optical Tracking System (OTS) is a graphical planning tool that allows for pre-operative and operative planning of surgical procedures. The OTS is indicated for use in surgical procedures in which anatomical landmarks are not clearly visible or where a desired target is close to critical structures.
Product codes
HAW
Device Description
The Optical Tracking System (OTS) provides an interactive, image-guided means of localizing targets in surgical procedures. A camera array tracks the position of probes and various tools. In addition to the camera array, the OTS consists of a computer workstation, application software, and probes. Upon registration of the system in the surgical environment, the surgeon selects points on the patient using a probe which are interpreted by the computer and related to corresponding points on the image.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
cranial and spinal
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
RSA Optical Tracking System (OTS) system and unit testing rigorously tests the functionality of the application software. The testing verifies the capabilities of the software to match and map markers on both the patient scan and the patient. The testing also verifies that the stereotactic CT and MR localizer transformation equations are correctly encoded into the application software. Further, the testing verifies the spatial accuracy of the digitizer, as well as the accuracy of the transformations which translate points from image space to screen space and screen space to image space.
Key Metrics
Not Found
Predicate Device(s)
Radionics Optical Tracking System (K964801), Surgical Navigation Technologies StealthStation Stereotactic System (K954276)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).
0
Appendix 1
Summary of Safety and Effectiveness
General Information
| Classification: | Class II |
|---|---|
| Common Name: | Surgical Planning and Guidance System |
| Device Trade Name: | Optical Tracking System (OTS) |
| Intended Uses: | The Optical Tracking System (OTS) is a graphical |
| planning tool that allows for pre-operative and | |
| operative planning of surgical procedures. The | |
| OTS is indicated for use in surgical procedures in | |
| which anatomical landmarks are not clearly visible | |
| or where a desired target is close to critical | |
| structures. | |
| Predicate Devices: | Radionics Optical Tracking System (K964801) |
| Surgical Navigation Technologies StealthStation | |
| Stereotactic System (K954276). | |
| Establishment Name and Address: | Radionics Software Applications, Inc. |
| 22 Terry Avenue | |
| Burlington, MA 01803 | |
| Phone (781) 272-1233 | |
| FAX (781) 272-2428 | |
| Contact Name and Phone: | Lisa Misterka Benati |
| (781) 272-1233 | |
| Date Summary was Prepared | December 8, 1997 |
| Establishment Registration Number: | 1222895 |
| Performance Standard: | None established under Section 514. |
Substantial Equivalence Determination
A summary of the information contained in this premarket notification that addresses safety and effectiveness follows.
1
Description of the Device and Basis for Substantial Equivalence
The Optical Tracking System (OTS) provides an interactive, image-guided means of localizing targets in surgical procedures. A camera array tracks the position of probes and various tools. In addition to the camera array, the OTS consists of a computer workstation, application software, and probes. Upon registration of the system in the surgical environment, the surgeon selects points on the patient using a probe which are interpreted by the computer and related to corresponding points on the image.
The OTS with cranial and spinal applications, addressed in this premarket notification, has the same intended use and similar technological characteristics as the commercially available Radionics OTS and the Surgical Navigation Technologies StealthStation Stereotactic System. The OTS with cranial and spinal applications retains the complete functionality of the commercially available OTS while incorporating the following modifications: a new version of OAS/OTS base application software written in a new software architecture, and a new add-on software module and spinal Dynamic Reference Frame to support spinal applications. Like the OTS with cranial and spinal applications, the SteathStation Stereotactic System supports both cranial and spinal applications.
Safety Summary
RSA Optical Tracking System (OTS) system and unit testing rigorously tests the functionality of the application software. The testing verifies the capabilities of the software to match and map markers on both the patient scan and the patient. The testing also verifies that the stereotactic CT and MR localizer transformation equations are correctly encoded into the application software. Further, the testing verifies the spatial accuracy of the digitizer, as well as the accuracy of the transformations which translate points from image space to screen space and screen space to image space.
General Safety and Effectiveness Concerns
The device labeling contains instructions for use. It includes indications for use, cautions, warnings, and user quality assurance procedures. The training and installation sessions ensure that the user understands all aspects of the Optical Tracking System: hardware, computer, and software and its intended functionality. This information promotes safe and effective use of the device.
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS). The seal features the department's name encircling a stylized caduceus symbol. The caduceus is composed of three intertwined strands and a cross at the top. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular pattern around the symbol.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 21 1998
Ms. Lisa Misterka Benati Senior Requlatory Engineer Radionics Software Applications, Inc. 22 Terry Avenue 01803-2516 Burlington, Massachusetts
K974602 Re: Optical Tracking System Trade Name: Regulatory Class: II Product Code: HAW Dated: March 10, 1998 Received: March 12, 1998
Dear Ms. Benati:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. ದ substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory In addition, FDA may publish further announcements action. Please note: concerning your device in the Federal Register. this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Ms. Benati
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html"
Sincerely yours,
Celia M. Witten, Ph.D., M.D.
Celia M. Witten, Ph.D., M.D. Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
The following are the indications for use of the OTS:
The Optical Tracking System (OTS) is a graphical planning tool that allows for pre-The Operative and operative planning of cranial and spinal surgical procedures. The OTS is operative and operative planing of certifical procedures in which anatomical landmarks are not clearly visible or where a desired target is close to critical structures.
Prescription Use
(Per 21 CFR 801.109)
bosley
(Division Sign-Off Division of General Restorative D 510(k) Number